期刊文献+

坎地沙坦降低心力衰竭死亡率和病残率研究

下载PDF
导出
摘要 2003年9月欧洲心脏病学会(ESC)年会公布了坎地沙坦降低心力衰竭死亡率和病残率研究(Candesartan in Heart Failure-Assessment of Reduction in Mortality,CHARM研究)结果,这是在心力衰竭病人中所做的最大规模临床研究.该结果显示长效血管紧张素Ⅱ的1型受体拮抗剂坎地沙坦(Cilexetil,AstraZeneca公司)可降低多种充血性心力衰竭病人(CHF)的心血管病死亡率和住院率[1-4].
作者 吴彦
出处 《中国民康医学》 2005年第8期460-462,共3页 Medical Journal of Chinese People’s Health
  • 相关文献

参考文献6

  • 1Pfeffer MA,Swedberg K,Granger CB,et al,for the CHARM Investigators and Committees.Effects of candesartan on mortality and morbidity in patients with chronic heart failure:the CHARM-Overall programme.Lancet,2003,362:759-66.
  • 2McMurray JJV,Ostergren J,Swedberg K,et al,for the CHARM Investigators and Committees.Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors:the CHARM-Added trial.Lancet,2003,362:767-71
  • 3Granger CB,McMurray JJV,Yusuf S,et al,for the CHARM Investigators and Committees.Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors:the CHARM-Alternative trial.Lancet,2003,362:772-776.
  • 4Yusuf S,Pfeffer MA,Swedberg K,et al,for the CHARM Investigators and Committees.Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction:the CHARM-Preserved Trial.Lancet,2003,362:777-81
  • 5Pitt B,Poole-Wilson PA,Segal R,et al.Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure:randomised trial--the Losartan Heart Failure Survival Study ELITE Ⅱ.Lancet.,2000,355:1582-1587.
  • 6Cohn JN,Tognoni G,for the Valsartan Heart Failure Trial Investigators.A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.N Engl J Med,2001,345:1667-1675.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部